NYSE · Healthcare
3M CO (MMM)
As-reported financials and recent SEC filings for 3M CO, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$24.95B
Net income
$3.25B
Net margin
13.0%
Diluted EPS
$6.00
ROE
68.5%
P/E (TTM)
31.7×
Market cap
$85.54B
Debt / equity
2.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $24.95B | $24.57B | $24.61B | $26.16B | $35.35B |
| Gross profit | $9.96B | $10.13B | $9.63B | $10.31B | $16.56B |
| Operating income | $4.63B | $4.82B | $-10.69B | $4.37B | $7.37B |
| Net income | $3.25B | $4.17B | $-7.00B | $5.78B | $5.92B |
| Diluted EPS | $6.00 | $7.55 | $-12.63 | $10.18 | $10.12 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-10
View on EDGAR →1442026-06-09
View on EDGAR →42026-06-09
View on EDGAR →32026-06-09
View on EDGAR →8-K2026-06-08
View on EDGAR →SD2026-05-28
View on EDGAR →8-K2026-05-13
View on EDGAR →42026-05-13
View on EDGAR →Go deeper on MMM
Search 3M CO’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.